Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart disease. [electronic resource]
Producer: 20130923Description: 64-9 p. digitalISSN:- 1874-1754
- Adult
- Antihypertensive Agents -- therapeutic use
- Bosentan
- Down Syndrome -- complications
- Familial Primary Pulmonary Hypertension
- Female
- Heart Defects, Congenital -- complications
- Humans
- Hypertension, Pulmonary -- complications
- Male
- Middle Aged
- Sulfonamides -- therapeutic use
- Survival Rate
- Time Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.